LAZCLUZE 80 mg/1
lazertinib · TABLET, FILM COATED · Janssen Biotech, Inc.
No Recall History
Plain English
LAZCLUZE is a tablet, film coated containing lazertinib at 80 mg/1, taken oral. Manufactured by Janssen Biotech, Inc..
Key Facts
- Brand Name
- LAZCLUZE
- Generic Name
- lazertinib
- NDC Code (Product)
57894-080- Manufacturer
- Janssen Biotech, Inc.
- Strength
- 80 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA219008
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 08/20/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is LAZCLUZE used for?
LAZCLUZE contains lazertinib. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is LAZCLUZE a controlled substance?
LAZCLUZE is not classified as a controlled substance by the DEA.
What is the generic name for LAZCLUZE?
The generic name for LAZCLUZE is lazertinib. There are no other listed brand versions of lazertinib.
What is the NDC code for LAZCLUZE 80 mg/1?
The NDC (National Drug Code) for LAZCLUZE 80 mg/1 is 57894-080, listed by Janssen Biotech, Inc..
Other LAZCLUZE Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)